After another successful year brings the total number of entries received to more than 150 in three years, our focus now turns to this year's first-round winners - who will make it to be one of the five coveted finalists?
In March 2012, BioQuarter announced the launch of i2eye Diagnostics Limited, creators of the world's first visual field analyser for children.
The BioQuarter Innovation Competition has received 100 entries in two years and created four new companies, delivering £60,000 in prizes.
Since we launched BioQuarter two years ago, we've spun out seven new companies focused on human and animal health.
Eleven companies already call Nine the BioQuarter their home. Why not join them?
We're the commercialisation arm of Europe's fastest-growing academic medical centre - a team of scientists and business people with more than 150 years of commercial experience in the biopharmaceutical industry.
We aim to accelerate the development of new treatments for human and animal diseases. We do this by working with researchers, industry and investors to create new drugs, diagnostic tools and medical devices. Key areas of research excellence in Edinburgh include regenerative medicine, inflammation and oncology.
,
,
,
